The historical rank and industry rank for Ningbo Menovo Pharmaceutical Co's OCF Margin % or its related term are showing as below:
SHSE:603538'
s OCF Margin % Range Over the Past 10 Years
Min: 0.75 Med: 14.24 Max: 20.28
Current: 10.03
During the past 13 years, the highest OCF Margin % of Ningbo Menovo Pharmaceutical Co was 20.28%. The lowest was 0.75%. And the median was 14.24%.
SHSE:603538's OCF Margin % is ranked better than 50.16% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs SHSE:603538: 10.03
Ningbo Menovo Pharmaceutical Co OCF Margin % Related Terms
Ningbo Menovo Pharmaceutical Co OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ningbo Menovo Pharmaceutical Co OCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Ningbo Menovo Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ningbo Menovo Pharmaceutical Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ningbo Menovo Pharmaceutical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Ningbo Menovo Pharmaceutical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ningbo Menovo Pharmaceutical Co (SHSE:603538) has a OCF Margin % of -7.75% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ningbo Menovo Pharmaceutical Co and its competitors. Over the past decade, Ningbo Menovo Pharmaceutical Co's OCF Margin % has ranged from 0.75 to 20.28. According to the industry distribution chart, Ningbo Menovo Pharmaceutical Co ranks #478 out of 959 companies in the Drug Manufacturers industry, placing it in the top 49.8%.
Is Ningbo Menovo Pharmaceutical Co's OCF Margin % too high?
Ningbo Menovo Pharmaceutical Co's current OCF Margin % is -7.75%. Over the past 10 years, this metric has ranged from a low of 0.75 to a high of 20.28. Based on the distribution chart, Ningbo Menovo Pharmaceutical Co ranks #478 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ningbo Menovo Pharmaceutical Co has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ningbo Menovo Pharmaceutical Co's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Ningbo Menovo Pharmaceutical Co ranks #478 out of 959 companies for OCF Margin %. This puts Ningbo Menovo Pharmaceutical Co in the upper half of its industry. The industry median OCF Margin % is 9.95. Historically, Ningbo Menovo Pharmaceutical Co's own OCF Margin % has ranged from 0.75 to 20.28 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ningbo Menovo Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ningbo Menovo Pharmaceutical Co's current OCF Margin % is -7.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningbo Menovo Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Ningbo Menovo Pharmaceutical Co (SHSE:603538) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥22.12, compared to a current price of ¥34.22 — trading 54.7% above its estimated fair value. The current OCF Margin % is -7.75%. Ningbo Menovo Pharmaceutical Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Ningbo Menovo Pharmaceutical Co (SHSE:603538), the current OCF Margin % is -7.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ningbo Menovo Pharmaceutical Co (SHSE:603538) Overvalued in 2026?
Based on GuruFocus' analysis, Ningbo Menovo Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥34.22 is trading 54.7% above its estimated GF Value™ of ¥22.12.
GuruFocus considers Ningbo Menovo Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SHSE:603538:
OCF Margin %: -7.75%
GF Value™: ¥22.12 vs. price of ¥34.22 (54.7% above fair value)
No single metric tells the full story. See the SHSE:603538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ningbo Menovo Pharmaceutical Co Business Description
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
65GF Score
Get the complete analysis for SHSE:603538
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603538 has been successfully added to your 
